Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

InBev Biopharmaceutical

Request full access

Precision fermentation for commercial scale animal-free proteins

ChinaFounded 2014Food

About InBev Biopharmaceutical

BioBrew is a corporate venture and separate R&D division of the world's largest brewer, Anheuser-Busch InBev (AB InBev), focused on bringing advanced precision fermentation to a commercial scale. Launched in 2019 by a small team and backed by ZX Ventures, the investment and innovation group of AB InBev, BioBrew was founded by Patrick O'Riordan, who also serves as the Global Head of BioBrew. O'Riordan, who holds a PhD in Food Science & Technology, was previously a co-founding partner at ZX Ventures.

The company leverages AB InBev's centuries of expertise in large-scale yeast fermentation to produce animal-free proteins and other sustainable bio-products. The business model centers on utilizing precision fermentation, a process where microorganisms like yeast are programmed to create specific products, such as proteins, instead of alcohol. This allows BioBrew to address the growing demand for alternative proteins driven by ecological concerns and the need for more efficient food systems. By applying its parent company's extensive knowledge and infrastructure in scaled fermentation, BioBrew aims to overcome the production capacity limitations faced by many smaller biotech firms in the alternative protein market.

BioBrew's primary service is to scale up the production of these bio-products for partners. A key example is its partnership with The EVERY Company, announced in April 2021, to ramp up the production of animal-free egg proteins. The technology works by programming yeast cells to deliver specific proteins, which are then cultivated in large fermentation tanks and fed with sugar. The resulting product can be purified into a protein powder for use as an ingredient by the food industry. AB InBev claims that one full BioBrew fermentation tank can produce a food equivalent of 5,000 cows or 300,000 chickens. The company operates a pilot plant for proteins in Germany and plans to build larger, separate production units.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.3/100
Industry
Food
Sector
Fermentation, Alternative Protein, precision fermentation
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2026 $28M $206M Xiner Technology · Deep Intelligent Pharma ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

InBev Biopharmaceutical in its local ecosystem

Live from Dealroom

The InBev Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Deep Intelligent Pharma
  • Xiner Technology
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about InBev Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See InBev Biopharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.